Related Experiment Video

Updated: Aug 1, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors

Yaohe Wang1, Shao-An Xue, Gunnel Hallden

  • 1Cancer Research UK Molecular Oncology Unit, Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK.

Cancer Research
|March 1, 2005
PubMed

Insights

A VAI-deleted adenovirus selectively replicates in EBV-positive tumors, offering a promising oncolytic virus therapy. This virus targets Epstein-Barr virus-associated cancers, showing high efficacy and reduced toxicity in preclinical models.

Area of Science:

  • Oncolytic virotherapy
  • Molecular virology
  • Cancer biology

Background:

  • Epstein-Barr virus (EBV) is linked to numerous human tumors, necessitating targeted therapeutic strategies.
  • Oncolytic adenoviruses are a promising platform for cancer treatment.
  • Adenovirus Virus-Associated I (VAI) RNAs are crucial for viral replication and mRNA translation.

Purpose of the Study:

  • To investigate the potential of VAI-deleted adenovirus as a replication-selective oncolytic agent targeting EBV-associated tumors.
  • To determine if EBV-encoded small RNA1 can functionally complement VAI-deleted adenoviruses in tumor cells.

Main Methods:

  • Construction and testing of a VAI-deleted adenovirus mutant.
  • Assessment of viral replication and cell toxicity in EBV-positive, EBV-negative, and normal human cells.
  • In vivo studies using EBV-positive tumor xenografts to evaluate antitumoral efficacy and toxicity.

Main Results:

  • VAI-deleted adenovirus demonstrated significantly higher replication in EBV-positive tumor cells compared to EBV-negative or normal cells.
  • High toxicity was observed specifically in EBV-positive tumor cells, with minimal impact on other cell types.
  • In vivo, the VAI-deleted adenovirus exhibited superior antitumoral efficacy and lower hepatotoxicity than wild-type adenovirus in EBV-positive xenografts.

Conclusions:

  • VAI-deleted adenovirus shows selective replication and oncolytic activity in EBV-positive tumor cells.
  • This engineered adenovirus represents a promising, targeted oncolytic virus for treating EBV-associated malignancies.
  • The findings support the development of VAI-deleted adenovirus as a novel cancer therapeutic.

More Related Videos

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...